Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10198-10209
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10198
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10198
Figure 6 Colonic nodular lymphoid hyperplasia in symptomatic patients constitutes a “minimal lesions colitis” that might be triggered by Nickel or other factors (such as immunodeficiency states, infections, hypersensitivity reactions, chronic constipation).
We speculate that minimal lesions colitis (MLC) could represent a distinct pathologic entity in a subset of irritable bowel syndrome (IBS) and systemic Ni allergy syndrome (SNAS) patients, and it might prelude to the development of inflammatory bowel disease (IBD).
- Citation: Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R, Lopetuso LR, Calò G, Fabbretti G, Brisigotti M, Stefanelli ML, Gasbarrini A. Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol 2016; 22(46): 10198-10209
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10198.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10198